Last reviewed · How we verify
Mecoral (chloralodol)
Mecoral (generic name: chloralodol) is a chloralodol drug. It is currently in unknown development.
Mecoral is thought to work by modulating the activity of certain enzymes or receptors in the body.
Chloralodol, also known as Chlorhexadol, is a small molecule hypnotic/sedative. It was previously a Schedule III drug in the United States, but it is no longer prescribed due to being off the market.
At a glance
| Generic name | chloralodol |
|---|---|
| Drug class | chloralodol |
| Therapeutic area | Other |
| Phase | unknown |
Mechanism of action
While the exact details of how Mecoral works are unclear, it is believed to affect the way the body processes certain chemicals or responds to stimuli. This can lead to changes in various physiological processes, although the specific effects and outcomes are not well understood. More research is needed to fully elucidate the mechanism of action of Mecoral.
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Mecoral CI brief — competitive landscape report
- Mecoral updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Mecoral
What is Mecoral?
How does Mecoral work?
What is the generic name of Mecoral?
What drug class is Mecoral in?
What development phase is Mecoral in?
Related
- Drug class: All chloralodol drugs
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Other
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing